Singapore: Researchers recently demonstrated that a single dose of the bivalent human papillomavirus (HPV) vaccine Cerva...
The on-going Ebola epidemic that has affected more than 5,000 people in five west African countries and how some experim...
Efforts to accelerate global use of new generation cholera vaccines gained significant momentum with the licensure of a ...
Singapore: From September 29-30, 2014, WHO organized an expert consultation to assess the groundwork of ebola vaccine de...
Singapore: The J Craig Venter Institute (JCVI) and Synthetic Genomics Vaccines (SGVI), US, are working with Novartis to ...
The rise of the flu - Early 2013 Avian Influenza A (H7N9) Outbreak Report • 44 DEAD, 135 INFECTED• First re...
Singapore: GlaxoSmithKline (GSK) has acquired Okairos, a specialist developer of vaccine platform technologies for $325 ...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem has achieved successful result ...
Singapore: Takeda Pharmaceutical has partnered with Chemo-Sero-Therapeutic Research Institute for the distribution of Ka...
Singapore: Recent breakthroughs in HIV prevention research have confirmed the promise of new options to help end the AID...
Singapore: The clinical trials for the experimental Ebola vaccine developed by GlaxoSmithKline in collaboration with the...
Singapore: With pandemics lurking at the back, achieving vaccine independence has become an essential part towards healt...
Singapore: Astellas pharma recently announced collaboration with Immunomic Therapeutics to develop and commercialize JRC...
Singapore: National Cancer Centre Singapore (NCCS) has launched a clinical trial of a new cancer vaccine, a form of canc...
Singapore: Australian firm, Admedus, has achieved positive endpoint in its phase I trial of a therapeutic vaccine for H...
Singapore: Teva Parenteral Medicines has issued a voluntary recall of eight lots of Adrucil (fluorouracil injection) due...
Singapore: Biolife Science has signed a letter of intent with Swiss company Pevion Biotech for the manufacture of Biolif...
Singapore: China's Yisheng Biopharma, a biopharmaceutical company developing vaccines, has developed a new vaccine for t...
